Study: People skip Parkinson’s, Alzheimer’s meds as prices rise

Study: People skip Parkinson’s, Alzheimer’s meds as prices rise
Rising drug costs are hampering the care of patients with debilitating neurological disorders like Parkinson's disease and Alzheimer's, a new study finds. Patients are less likely to fill necessary ... read more
Source: Bing NewsPublished on 2020-02-19